| Dr Daniel Adam Cuzzone, MD | |
|
The Emory Clinic Inc 1365 Clifton Rd Ne, Atlanta, GA 30368-2913 | |
| (404) 778-4500 | |
| Not Available |
| Full Name | Dr Daniel Adam Cuzzone |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 15 Years |
| Location | The Emory Clinic Inc 1365 Clifton Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316171572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 277081 (New York) | Secondary |
| 208200000X | Plastic Surgery | 81027 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory University Hospital Midtown | Atlanta, GA | Hospital |
| Emory University Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count-a key measure of immune system health-is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others.
A New York Times/CBS News/Quinnipiac poll finds that even in the midst of the Medicare debate, presumptive GOP presidential nominee Mitt Romney appears to have gained ground in Florida and other swing states.
› Verified 7 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count-a key measure of immune system health-is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others.
A New York Times/CBS News/Quinnipiac poll finds that even in the midst of the Medicare debate, presumptive GOP presidential nominee Mitt Romney appears to have gained ground in Florida and other swing states.
› Verified 7 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count-a key measure of immune system health-is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others.
A New York Times/CBS News/Quinnipiac poll finds that even in the midst of the Medicare debate, presumptive GOP presidential nominee Mitt Romney appears to have gained ground in Florida and other swing states.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Adam Cuzzone, MD 12 Yew St, Norwalk, CT 06850-1231 Ph: (203) 856-0680 | Dr Daniel Adam Cuzzone, MD The Emory Clinic Inc 1365 Clifton Rd Ne, Atlanta, GA 30368-2913 Ph: (404) 778-4500 |
News Archive
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count-a key measure of immune system health-is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others.
A New York Times/CBS News/Quinnipiac poll finds that even in the midst of the Medicare debate, presumptive GOP presidential nominee Mitt Romney appears to have gained ground in Florida and other swing states.
› Verified 7 days ago
Mark F Deutsch, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 980 Johnson Ferry Rd Ne, Suite 760, Atlanta, GA 30342 Phone: 770-461-4824 Fax: 770-461-2601 | |
Theresa Wang, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1218 W Paces Ferry Rd Nw, Atlanta, GA 30327 Phone: 404-480-4888 | |
Dr. Thomas Hagopian, M.D. Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 99 Krog St Ne Unit C110, Atlanta, GA 30307 Phone: 404-885-8542 Fax: 404-885-8547 | |
Dr. Varun Gupta, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 20 Glenlake Pkwy, Atlanta, GA 30328 Phone: 404-365-0966 | |
Dr. Lisa M. Difrancesco, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1800 Howell Mill Rd Nw, Suite 400, Atlanta, GA 30318 Phone: 404-377-3474 Fax: 404-377-0433 | |
Dr. Foad Nahai, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3200 Downwood Cir Nw, 640, Atlanta, GA 30327 Phone: 404-351-0051 Fax: 404-351-0632 | |
Allyson B Maske, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 975 Johnson Ferry Rd Ne, Suite 500, Atlanta, GA 30342 Phone: 404-256-1311 Fax: 404-705-2766 |